Search

everythinglearnresearchcommunity

for

Search:↓

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Acne is more common in men with male pattern baldness due to increased hormone levels.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Some nonsurgical hair loss treatments are effective, especially if started early.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Fractional microneedle radiofrequency is a safe and effective skin treatment with minimal serious side effects.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Hair restoration surgery in patients with prior neurosurgery or radiation treatment can have risks like infection and poor wound healing, so it's important to discuss these with the patient.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.